Announced Wed, 24 Jun · 17:34 IST
Shilpa Biologicals settles dispute with Sartorius for Rs 9 crore
SHILPAMED · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-0.6%1-day move
₹578.50
prior close
₹584.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-1.3-1.9-2.1-2.0-0.6+3.8-1.3+3.7+5.4+3.2+7.1+7.3——
Up moveDown movePending
AI summary
Shilpa Medicare's material subsidiary Shilpa Biologicals has settled a commercial dispute with Sartorius Stedim India by paying Rs 9 crore before the Bengaluru Commercial Court. Sartorius had originally claimed about Rs 20.13 crore plus interest. The settlement, executed on 23 June 2026, is limited to this Rs 9 crore payment. No regulatory violation is alleged, and financial impact is confined to the settlement amount.
Likely market impact
Saves ongoing litigation costs; subsidiary pays Rs 9 crore, about 55 percent lower than the original Rs 20.13 crore claim. Limited financial hit on the listed entity.